Abstract:Introduction: Human studies show congenital heart disease (CHD) has a complex non-Mendelian genetic etiology. We previously conducted a recessive N-ethyl-N-nitrosourea (ENU) mouse mutagenesis screen using fetal ultrasound and recovered over 150 recessive mutations causing CHD. In the present study, we conducted a sensitized screen with driver mutations to recover dominant mutations causing CHD. We hypothesize this dominant screen can help to elucidate the complex genetic architecture of CHD. Methods: G1 males with heterozygous ENU induced mutations were mated to females harboring heterozygous “driver” mutation in Kif7, Anks6, or Sap130 that can cause CHD when homozygous. The resulting G2 offspring were screened for CHD by fetal ultrasound. Mutations in G1 males were identified by whole exome sequencing and the G2 offspring were genotyped using Ion Torrent sequencing. Linkage analysis was conducted to identify the CHD causing mutation. Results: We found 9.3% of the G1 pedigrees (n=551) yielded CHD mutants, similar to the 8.2% observed in the previous recessive screen. However, only 2.5 mutants were recovered per line vs. 4.5 in the recessive screen despite having screened similar number of embryos, supporting non-Mendelian genetics in the dominant screen. Genotype-phenotype analysis revealed only 32%, 45%, and 55% of the CHD mutants recovered carried the Kif7, Anks6, or Sap130 driver mutations, respectively, suggesting the driver mutations are not required for CHD pathogenesis. For mouse line 4142 with DORV/OA, we identified a heterozygous p21/Rac-activated kinase 2 ( Pak2) mutation as disease causing (p=4.8e-12). CHD penetrance was 83% among Pak2 +/m embryos. Among surviving 4142 G2 offspring, only 14% have the Pak2 mutation vs. 50% expected. We observed 75% of the surviving Pak2 mutant mice also carry a mutation in Zbtb2, a gene identified to regulate p21, suggesting this may act as a protective modifier. Conclusion: We showed the feasibility of using mouse mutagenesis to recover dominant mutations causing CHD, and showed for the first time a role for Pak2 in CHD. These findings demonstrate that the genetic diversity created by ENU mutagenesis can provide the genomic context to investigate the complex genetics and genetic architecture of CHD.

Knockout mice are an important tool for human monogenic heart disease studies

Predicting human disease mutations and identifying drug targets from mouse gene knockout phenotyping campaigns

Disease model discovery from 3,328 gene knockouts by The International Mouse Phenotyping Consortium

New models for human disease from the International Mouse Phenotyping Consortium

Extensive Identification of Genes Involved in Congenital and Structural Heart Disorders and Cardiomyopathy

The International Mouse Phenotyping Consortium: comprehensive knockout phenotyping underpinning the study of human disease

Modeling of Transgenic Mice Cardiac- Specifically Overexpressing Human KCNE4 Gene

Interpretation of murine models of cardiac disease is enhanced by consideration of divergently expressed human-mouse orthologous genes

Abstract 16596: Dominant Mouse Mutagenesis Screen Unveils a Complex Genetic Architecture for Congenital Heart Disease

A Machine Learning Classifier to Identify and Prioritise Genes Associated with Cardiac Development

Gene expression analysis to identify mechanisms underlying heart failure susceptibility in mice and humans

ENU-based dominant genetic screen identifies contractile and neuronal gene mutations in congenital heart disease

A Modifier Screen Identifies DNAJB6 As a Cardiomyopathy Susceptibility Gene.

Abstract 14427: Differences in Molecular Phenotype in Mouse and Human Hypertrophic Cardiomyopathy Suggest Need for Precision Medicine Approach to Treatment Based on Human Studies

The Expression Profile Analysis of NKX2-5 Knock-out Embryonic Mice to Explore the Pathogenesis of Congenital Heart Disease.

Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathy

The International Mouse Phenotyping Consortium Web Portal, a unified point of access for knockout mice and related phenotyping data

Efficient and Fast Generation of Relevant Disease Mouse Models by In Vitro and In Vivo Gene Editing of Zygotes

Human and mouse essentiality screens as a resource for disease gene discovery

A mouse model for adult cardiac-specific gene deletion with CRISPR/Cas9

Impact of Essential Genes on the Success of Genome Editing Experiments Generating 3,313 New Genetically Engineered Mouse Lines